Joinn Laboratories IPO: Pioneer of Commercial GLP Laboratories in China Shows Promise
Joinn Laboratories, a non-clinical CRO focused on drug safety assessment has filed for a secondary listing on the Hong Kong Stock Exchange and...
447 Views
New Horizon Health IPO Valuation: Healthy Valuation
The company has set the terms for its IPO, where it plans to raise net proceeds of US$176-208m (approx. HK$1.4-1.6bn) through the issuance of 76.6m...
511 Views
Suzhou Basecare Medical IPO: Trading Debut
Basecare priced its IPO at HK$27.36 and closed 14% up at HK$31.20 in the grey market. Our DCF sensitivity analysis shows that the IPO price is...
442 Views
ECM Weekly (7 February 2021) - Kuaishou, New Horizon, SciClone, Cloopen
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
482 Views
New Horizon IPO: Only Undemanding Assumptions Needed
We think the proposed valuation of New Horizon Health's (NHH HK) IPO is reasonable using undemanding assumptions and would participate in the...
527 Views